Prenetics Global Limited (PRENW)

USD 0.01

(19.0%)

Market Cap (In USD)

70.49 Million

Revenue (In USD)

21.74 Million

Net Income (In USD)

-62.72 Million

Avg. Volume

-

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.0091-0.012
PE
-
EPS
-
Beta Value
-0.21
ISIN
KYG722451146
CUSIP
G72245114
CIK
1876431
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Mr. Sheng Wu Yeung
Employee Count
-
Website
https://www.prenetics.com
Ipo Date
Details
Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.